1. Home
  2. ACOG vs BOOM Comparison

ACOG vs BOOM Comparison

Compare ACOG & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • BOOM
  • Stock Information
  • Founded
  • ACOG 2000
  • BOOM 1965
  • Country
  • ACOG Canada
  • BOOM United States
  • Employees
  • ACOG N/A
  • BOOM N/A
  • Industry
  • ACOG
  • BOOM Industrial Specialties
  • Sector
  • ACOG
  • BOOM Industrials
  • Exchange
  • ACOG Nasdaq
  • BOOM Nasdaq
  • Market Cap
  • ACOG 130.9M
  • BOOM 124.4M
  • IPO Year
  • ACOG N/A
  • BOOM N/A
  • Fundamental
  • Price
  • ACOG $6.18
  • BOOM $6.18
  • Analyst Decision
  • ACOG Strong Buy
  • BOOM Hold
  • Analyst Count
  • ACOG 1
  • BOOM 1
  • Target Price
  • ACOG $18.00
  • BOOM $8.50
  • AVG Volume (30 Days)
  • ACOG 110.9K
  • BOOM 206.3K
  • Earning Date
  • ACOG 11-13-2025
  • BOOM 11-04-2025
  • Dividend Yield
  • ACOG N/A
  • BOOM N/A
  • EPS Growth
  • ACOG N/A
  • BOOM N/A
  • EPS
  • ACOG N/A
  • BOOM N/A
  • Revenue
  • ACOG $7,427,199.00
  • BOOM $618,683,000.00
  • Revenue This Year
  • ACOG N/A
  • BOOM N/A
  • Revenue Next Year
  • ACOG $101.16
  • BOOM $2.70
  • P/E Ratio
  • ACOG N/A
  • BOOM N/A
  • Revenue Growth
  • ACOG N/A
  • BOOM N/A
  • 52 Week Low
  • ACOG $3.75
  • BOOM $5.46
  • 52 Week High
  • ACOG $11.54
  • BOOM $9.92
  • Technical
  • Relative Strength Index (RSI)
  • ACOG 47.49
  • BOOM 42.71
  • Support Level
  • ACOG $5.66
  • BOOM $5.46
  • Resistance Level
  • ACOG $6.33
  • BOOM $6.03
  • Average True Range (ATR)
  • ACOG 0.54
  • BOOM 0.31
  • MACD
  • ACOG 0.07
  • BOOM -0.00
  • Stochastic Oscillator
  • ACOG 73.52
  • BOOM 81.46

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Share on Social Networks: